Reviews
In this edition, we have reviewed Landmark Cars Ltd. and Lincoln Pharmaceuticals Ltd. We suggest our readerinvestors to HOLD Landmark Cars Ltd. and Lincoln Pharmaceuticals Ltd.
We had recommended Landmark Cars Ltd. in Volume 39, Issue No. 3 dated January 1, 2024 — January 14, 2024, under the ‘Cover Story’ segment. The recommended price for the stock was ₹784. We had recommended the stock based on significant growth from new brands, a strategic focus on cost rationalisation, and operational optimisation. Landmark Cars is a leading Indian premium automotive retail business, with dealerships for Mercedes-Benz, Honda, Jeep, Volkswagen and Renault.
To read the entire article, you must be a DSIJ magazine subscriber.
Current print subscribers click here to login
Subscribe now to get DSIJ All Access